Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Sepsis involves complex Toll-like receptor (TLR) signaling, leading to broad inflammation that limits single-target therapies.
• Developing biomaterials to modulate innate immune cell responses is a promising strategy for inflammatory diseases.

Purpose of the Study:

• To develop cargo-less particles as a single-agent, multi-target platform for broad anti-inflammatory action.
• To investigate the immunomodulatory properties and mechanisms of these particles.

Main Methods:

• Particles were synthesized from poly(lactic-co-glycolic acid) (PLGA) and poly(lactic acid) (PLA) using different surfactants (PEMA, PVA).
• Immunomodulatory effects were assessed by measuring costimulatory molecule expression and cytokine secretion in response to TLR agonists.
• Biochemical pathways were analyzed using TRanscriptional Activity CEll aRrays (TRACER).
• Efficacy was evaluated in an LPS-induced endotoxemia mouse model.

Main Results:

• PLA-PEMA particles demonstrated potent anti-inflammatory effects, blunting responses to both extracellular (TLR4) and intracellular (TLR9) agonists.
• PLA-PEMA particles modulated pathways involving IRF1, STAT1, and AP-1.
• PLA-PEMA particles significantly improved survival in a lethal LPS-induced endotoxemia mouse model.
• Particle properties like molecular weight, polymer composition, and charge influenced immunomodulatory effects.

Conclusions:

• Cargo-less particles offer a versatile platform for broad anti-inflammatory action against innate immune cells.
• These particles modulate multiple biological pathways involved in inflammation, presenting a potential therapeutic strategy for severe inflammatory conditions like sepsis.